HEATHER JEFFERSON: Open Payments
NPI 1114688801 · LEONARDTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 26 payments from 8 companies in 2025. Trend: 2023 $271 · 2024 $665 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $271 |
| ABBVIE INC. | 3 | $64 |
| GENZYME CORPORATION | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 5 | $38 |
| Janssen Biotech, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $15 |
Products named: REZDIFFRA, DUPIXENT, VOQUEZNA, TREMFYA, XIFAXAN, CREON, LINZESS, RINVOQ.
Industry payments across MD — which companies pay providers there.
